Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-14
DOI
10.3389/fphar.2021.633821
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A cytokine network profile delineates a common Th1/Be1 pro‐inflammatory group of patients in four systemic autoimmune diseases
- (2021) Quentin Simon et al. Arthritis & Rheumatology
- Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases
- (2020) Peter Blomgren et al. ACS Medicinal Chemistry Letters
- Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers
- (2020) François Chasset et al. RHEUMATOLOGY
- Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases
- (2020) Jiao Jiang et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Mapping systemic lupus erythematosus heterogeneity at the single-cell level
- (2020) Djamel Nehar-Belaid et al. NATURE IMMUNOLOGY
- Kinase inhibition in autoimmunity and inflammation
- (2020) Ali A. Zarrin et al. NATURE REVIEWS DRUG DISCOVERY
- Response to ustekinumab treatment in patients with systemic lupus erythematosus is linked to suppression of serum interferon gamma levels
- (2020) Matteo Cesaroni et al. Arthritis & Rheumatology
- Inhibition of IRF5 hyperactivation protects from lupus onset and severity
- (2020) Su Song et al. JOURNAL OF CLINICAL INVESTIGATION
- Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity
- (2020) Antonios Psarras et al. Nature Communications
- Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
- (2020) Guillermo Barturen et al. Arthritis & Rheumatology
- Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
- (2019) Richard Furie et al. JOURNAL OF CLINICAL INVESTIGATION
- Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis
- (2019) Bharati Matta et al. CYTOKINE
- Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update
- (2019) Satoshi Kubo et al. Expert Review of Clinical Immunology
- Shared and Distinct Functions of Type I and Type III Interferons
- (2019) Helen M. Lazear et al. IMMUNITY
- Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models
- (2019) Philipp Haselmayer et al. JOURNAL OF IMMUNOLOGY
- Genomic Identification of Low-Density Granulocytes and Analysis of Their Role in the Pathogenesis of Systemic Lupus Erythematosus
- (2019) Brian J. Kegerreis et al. JOURNAL OF IMMUNOLOGY
- CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis
- (2019) Roberto Lande et al. Nature Communications
- Tofacitinib in Amyopathic Dermatomyositis–Associated Interstitial Lung Disease
- (2019) Zhiwei Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunologic findings precede rapid lupus flare after transient steroid therapy
- (2019) Rufei Lu et al. Scientific Reports
- Interferon-Stimulated Genes: What Do They All Do?
- (2019) John W. Schoggins Annual Review of Virology
- Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus
- (2019) Pragnesh Mistry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Maintenance of efficacy and safety of ustekinumab through 1 year in a randomized phase II trial of patients with active systemic lupus erythematosus
- (2019) Ronald F. van Vollenhoven et al. Arthritis & Rheumatology
- Neutrophils—Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
- (2019) Lina Wirestam et al. Frontiers in Immunology
- IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study
- (2019) Frederic A Houssiau et al. ANNALS OF THE RHEUMATIC DISEASES
- A Successful Trial for Lupus — How Good Is Good Enough?
- (2019) Jane E. Salmon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutrophil Extracellular Traps in Autoimmunity and Allergy: Immune Complexes at Work
- (2019) Vanessa Granger et al. Frontiers in Immunology
- TheSTAT4SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE
- (2018) Niklas Hagberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa
- (2018) Mrinal K Sarkar et al. ANNALS OF THE RHEUMATIC DISEASES
- Targeting interferons and their pathways in systemic lupus erythematosus
- (2018) François Chasset et al. AUTOIMMUNITY REVIEWS
- JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis
- (2018) Leandro Ladislau et al. BRAIN
- Computerized planimetry to assess clinical responsiveness in a phase II randomized trial of topical R333 for discoid lupus erythematosus
- (2018) J.K. Presto et al. BRITISH JOURNAL OF DERMATOLOGY
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
- (2018) Daniel J Wallace et al. LANCET
- ABBV-105, a selective and irreversible inhibitor of Bruton’s Tyrosine Kinase (BTK), is efficacious in multiple preclinical models of inflammation
- (2018) Christian Goess et al. Modern Rheumatology
- Type I interferon in rheumatic diseases
- (2018) Theresa L. Wampler Muskardin et al. Nature Reviews Rheumatology
- Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8
- (2018) Marie Dominique Ah Kioon et al. Science Translational Medicine
- Longitudinal Stratification of Gene Expression Reveals Three SLE Groups of Disease Activity Progression
- (2018) Daniel Toro-Domínguez et al. Arthritis & Rheumatology
- Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System
- (2018) Satoshi Kubo et al. Frontiers in Immunology
- Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study
- (2018) Ronald F van Vollenhoven et al. LANCET
- Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features
- (2018) Y. M. El-Sherbiny et al. Scientific Reports
- Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial
- (2018) Philip Mease et al. LANCET
- Monitoring disease activity in systemic lupus erythematosus with single-molecule array digital ELISA quantification of serum interferon-α
- (2018) Alexis Mathian et al. Arthritis & Rheumatology
- Type I Interferons in Autoimmune Disease
- (2018) Mary K. Crow et al. Annual Review of Pathology-Mechanisms of Disease
- Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness
- (2017) Ioanna E. Galani et al. IMMUNITY
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
- (2016) Munther Khamashta et al. ANNALS OF THE RHEUMATIC DISEASES
- Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification
- (2016) Melissa E Munroe et al. ANNALS OF THE RHEUMATIC DISEASES
- Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity
- (2016) Franck J. Barrat et al. Annual Review of Medicine
- Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity
- (2016) Vanja Sisirak et al. CELL
- Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
- (2016) Romain Banchereau et al. CELL
- The genetic basis of systemic lupus erythematosus: What are the risk factors and what have we learned
- (2016) Maria Teruel et al. JOURNAL OF AUTOIMMUNITY
- Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies
- (2016) Rufei Lu et al. JOURNAL OF AUTOIMMUNITY
- Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
- (2016) Mathieu P. Rodero et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Low-density granulocytes: functionally distinct, immature neutrophils in rheumatoid arthritis with altered properties and defective TNF signalling
- (2016) Helen L. Wright et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease
- (2016) Christian Lood et al. NATURE MEDICINE
- Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study
- (2016) Julie Ducreux et al. RHEUMATOLOGY
- Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis
- (2016) Noémie Jourde-Chiche et al. RHEUMATOLOGY
- Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies
- (2016) L. Ekholm et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases
- (2016) Sarthak Gupta et al. Arthritis & Rheumatology
- Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease
- (2016) Clio P. Mavragani et al. Arthritis & Rheumatology
- Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE
- (2016) Aparna Mahajan et al. Frontiers in Immunology
- RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities
- (2016) Richa Rai et al. PLoS One
- The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis
- (2015) Zana Brkic et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis
- (2015) Theresa Wampler Muskardin et al. ANNALS OF THE RHEUMATIC DISEASES
- A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
- (2015) Kenneth C Kalunian et al. ANNALS OF THE RHEUMATIC DISEASES
- Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease
- (2015) Guang-Nian Zhao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis
- (2015) Adrianos Nezos et al. JOURNAL OF AUTOIMMUNITY
- Suppression of T Cell Activation and Collagen Accumulation by an Anti-IFNAR1 mAb, Anifrolumab, in Adult Patients with Systemic Sclerosis
- (2015) Xiang Guo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Interferon regulatory factors: critical mediators of human lupus
- (2015) Mark A. Jensen et al. Translational Research
- Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus
- (2014) S N Kariuki et al. GENES AND IMMUNITY
- Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis
- (2014) L. Tang et al. GENETICS AND MOLECULAR RESEARCH
- Cutting Edge: Autoimmune Disease Risk Variant of STAT4 Confers Increased Sensitivity to IFN- in Lupus Patients In Vivo
- (2014) S. N. Kariuki et al. JOURNAL OF IMMUNOLOGY
- Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study
- (2014) Avram Goldberg et al. ARTHRITIS RESEARCH & THERAPY
- The type I IFN signature as a biomarker of preclinical rheumatoid arthritis
- (2013) Joyce Lübbers et al. ANNALS OF THE RHEUMATIC DISEASES
- A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
- (2013) Brandon W Higgs et al. ANNALS OF THE RHEUMATIC DISEASES
- IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
- (2013) HyeonJoo Cheon et al. EMBO JOURNAL
- Little Peptide, Big Effects: The Role of LL-37 in Inflammation and Autoimmune Disease
- (2013) J. M. Kahlenberg et al. JOURNAL OF IMMUNOLOGY
- Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
- (2013) Lenny van Bon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo-controlled, double-blind, dose-escalation study
- (2012) Jacqueline M. McBride et al. ARTHRITIS AND RHEUMATISM
- The interferon signature andSTAT1expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment
- (2012) Rachael A. Gordon et al. ARTHRITIS AND RHEUMATISM
- IFN-α subtypes: distinct biological activities in anti-viral therapy
- (2012) K Gibbert et al. BRITISH JOURNAL OF PHARMACOLOGY
- The interferons and their receptors-distribution and regulation
- (2012) Nicole A de Weerd et al. IMMUNOLOGY AND CELL BIOLOGY
- Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases
- (2012) J. C. Hall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus
- (2011) Timothy B Niewold et al. ANNALS OF THE RHEUMATIC DISEASES
- Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
- (2011) B. W. Higgs et al. ANNALS OF THE RHEUMATIC DISEASES
- Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus
- (2011) Rachel Klein et al. ARCHIVES OF DERMATOLOGY
- Immature muscle precursors are a source of interferon-β in myositis: Role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation
- (2011) Anne Tournadre et al. ARTHRITIS AND RHEUMATISM
- Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis
- (2011) S A Greenberg et al. GENES AND IMMUNITY
- Autoimmune Disease Risk Variant of IFIH1 Is Associated with Increased Sensitivity to IFN- and Serologic Autoimmunity in Lupus Patients
- (2011) T. Robinson et al. JOURNAL OF IMMUNOLOGY
- Systems Biology of Interferon Responses
- (2011) Paul Hertzog et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study
- (2011) David Fiorentino et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus
- (2011) R. Lande et al. Science Translational Medicine
- Neutrophils and interferon-α-producing cells: who produces interferon in lupus?
- (2011) Patrice Decker ARTHRITIS RESEARCH & THERAPY
- Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-β/α ratios in rheumatoid arthritis patients: A post hoc analysis of a predominantly Hispanic cohort
- (2010) Clio P. Mavragani et al. ARTHRITIS AND RHEUMATISM
- Systemic sclerosis and lupus: Points in an interferon-mediated continuum
- (2010) Shervin Assassi et al. ARTHRITIS AND RHEUMATISM
- STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling
- (2010) N Gestermann et al. GENES AND IMMUNITY
- The Role of Genetic Variation Near Interferon-Kappa in Systemic Lupus Erythematosus
- (2010) Isaac T. W. Harley et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs
- (2010) M. F. Denny et al. JOURNAL OF IMMUNOLOGY
- Evidence for a Pathophysiological Role of Keratinocyte-Derived Type III Interferon (IFNλ) in Cutaneous Lupus Erythematosus
- (2010) Sabine Zahn et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Type I interferons: crucial participants in disease amplification in autoimmunity
- (2010) John C. Hall et al. Nature Reviews Rheumatology
- Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus
- (2010) Silvia N Kariuki et al. ARTHRITIS RESEARCH & THERAPY
- The CGGGG insertion/deletion polymorphism of theIRF5promoter is a strong risk factor for primary Sjögren's syndrome
- (2009) Corinne Miceli-Richard et al. ARTHRITIS AND RHEUMATISM
- STAT4is a genetic risk factor for systemic sclerosis having additive effects withIRF5on disease susceptibility and related pulmonary fibrosis
- (2009) P. Dieudé et al. ARTHRITIS AND RHEUMATISM
- Elevated serum interferon-α activity in juvenile dermatomyositis: Associations with disease activity at diagnosis and after thirty-six months of therapy
- (2009) Timothy B. Niewold et al. ARTHRITIS AND RHEUMATISM
- RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease
- (2009) Shinji Sato et al. ARTHRITIS AND RHEUMATISM
- Peripheral blood gene expression profiling in Sjögren's syndrome
- (2009) E S Emamian et al. GENES AND IMMUNITY
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
- (2009) Dipyaman Ganguly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IFN Regulatory Factor 5 Is Required for Disease Development in the Fc RIIB-/-Yaa and Fc RIIB-/- Mouse Models of Systemic Lupus Erythematosus
- (2009) C. Richez et al. JOURNAL OF IMMUNOLOGY
- Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus
- (2009) M Petri et al. LUPUS
- Cytokines and Cytokine Profiles in Human Autoimmune Diseases and Animal Models of Autoimmunity
- (2009) Manfred Kunz et al. MEDIATORS OF INFLAMMATION
- Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA)
- (2008) M F Roelofs et al. ANNALS OF THE RHEUMATIC DISEASES
- Lack of association between the interferon- signature and longitudinal changes in disease activity in systemic lupus erythematosus
- (2008) C Landolt-Marticorena et al. ANNALS OF THE RHEUMATIC DISEASES
- Induction of interferon‐α by scleroderma sera containing autoantibodies to topoisomerase I: Association of higher interferon‐α activity with lung fibrosis
- (2008) Daniel Kim et al. ARTHRITIS AND RHEUMATISM
- Association of the IRF5 risk haplotype with high serum interferon-α activity in systemic lupus erythematosus patients
- (2008) Timothy B. Niewold et al. ARTHRITIS AND RHEUMATISM
- ThePTPN22C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-α activity and low tumor necrosis factor α levels in patients with lupus
- (2008) Silvia N. Kariuki et al. ARTHRITIS AND RHEUMATISM
- Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome
- (2008) G Nordmark et al. GENES AND IMMUNITY
- TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon–response genes
- (2008) Anna Yarilina et al. NATURE IMMUNOLOGY
- Specificity of the STAT4 Genetic Association for Severe Disease Manifestations of Systemic Lupus Erythematosus
- (2008) Kimberly E. Taylor et al. PLoS Genetics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started